Edgewise Therapeutics
NASDAQ: EWTXBoulder, US · Founded 2017 · Delaware corporation · 1 known investors
Founders & leadership
Edgewise Therapeutics was founded in 2017 by Kevin Koch and Alan Russell.
KK
Kevin KochCo-founder
AR
Alan RussellCo-founder
KH
Kenneth HarrisonNamed on SEC filing
Board
PT
Peter ThompsonBoard director
JR
Jonathan RootBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$120.1M disclosed across 2 rounds · 2019–2020
▶$95MraisedDec 2020 · 21 investors · BiotechnologyRule 506(b)
▶$95MraisedDec 2020 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin KochExecutive Officer, Director
- Peter ThompsonDirector
- Kenneth HarrisonDirector
- Jonathan RootDirector
- Alan RussellDirector
- Offering amount
- $95M
- Amount sold
- $95M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$25.1MraisedSep 2019 · 6 investors · Other TechnologyRule 506(b)
▶$25.1MraisedSep 2019 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin KochExecutive Officer, Director
- Peter ThompsonDirector
- Kenneth HarrisonDirector
- Jonathan RootDirector
- Alan RussellDirector
- Offering amount
- $50.1M
- Amount sold
- $25.1M
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Edgewise Therapeutics?
- Edgewise Therapeutics was founded by Kevin Koch, Alan Russell in 2017.
- Who are Edgewise Therapeutics's investors?
- Edgewise Therapeutics's investors include Foresite Capital.
- How much funding has Edgewise Therapeutics raised?
- Edgewise Therapeutics has disclosed $120.1M raised across 2 rounds.
- Where is Edgewise Therapeutics headquartered?
- Edgewise Therapeutics is headquartered in Boulder, US.